Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 51

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus

Liu, Yaqian, She, Pengfei, Xu, Lanlan, Chen, Lihua, Li, Yimin, Liu, Shasha, Li, Zehao, Hussain, Zubair, Wu, Yong · 2021 · Frontiers in Microbiology

Abstract

Staphylococcus aureus has increasingly attracted global attention as a major opportunistic human pathogen owing to the emergence of biofilms (BFs) and persisters that are known to increase its antibiotic resistance. However, there are still no effective antimicrobial agents in clinical settings. This study investigated the antimicrobial activity of penfluridol (PF), a long-acting antipsychotic drug, against S. aureus and its clinical isolates via drug repurposing. PF exhibited strong bactericidal activity against S. aureus , with a minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 4–8 and 16–32 μg/ml, respectively. PF could significantly inhibit biofilm formation and eradicate 24 h preformed biofilms of S. aureus in a dose-dependent manner. Furthermore, PF could effectively kill methicillin-resistant S. aureus (MRSA) persister cells and demonstrated considerable efficacy in a mouse model of subcutaneous abscess, skin wound infection, and acute peritonitis caused by MRSA. Notably, PF exerted almost no hemolysis activity on human erythrocytes, with limited cytotoxicity and low tendency to cause resistance. Additionally, PF induced bacterial membrane permeability and ATP release and further caused membrane disruption, which may be the underlying antibacterial mechanism of PF. In summary, our findings suggest that PF has the potential to serve as a novel antimicrobial agent against S. aureus biofilm- or persister-related infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2021.727692

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. Abraham, 2016, Going beyond the control of quorum-sensing to combat biofilm infections, Antibiotics, 5, 3, 10.3390/antibiotics5010003 · DOI
  2. Arciola, 2018, Implant infections: adhesion, biofilm formation and immune evasion, Nat. Rev. Microbiol., 16, 397, 10.1038/s41579-018-0019-y · DOI · Paper page
  3. Balant-Gorgia, 1987, Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring, Clin. Pharmacokinet., 13, 65, 10.2165/00003088-198713020-00001 · DOI
  4. Brynildsen, 2013, Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production, Nat. Biotechnol., 31, 160, 10.1038/nbt.2458 · DOI · Paper page
  5. Cuaron, 2013, Tea tree oil-induced transcriptional alterations in Staphylococcus aureus, Phytother. Res., 27, 390, 10.1002/ptr.4738 · DOI
  6. DelMain, 2020, Stochastic expression of sae-dependent virulence genes during Staphylococcus aureus biofilm development is dependent on SaeS, MBio, 11, e03081, 10.1128/mBio.03081-19 · DOI
  7. Dias, 2017, New potent membrane-targeting antibacterial peptides from viral capsid proteins, Front. Microbiol., 8, 775, 10.3389/fmicb.2017.00775 · DOI
  8. Domka, 2007, Temporal gene-expression in Escherichia coli K-12 biofilms, Environ. Microbiol., 9, 332, 10.1111/j.1462-2920.2006.01143.x · DOI · Paper page
  9. Elliott, 2020, An amphipathic peptide with antibiotic activity against multidrug-resistant gram-negative bacteria, Nat. Commun., 11, 3184, 10.1038/s41467-020-16950-x · DOI · Paper page
  10. Friedman, 2006, Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus, Antimicrob. Agents Chemother., 50, 2137, 10.1128/AAC.00039-06 · DOI · Paper page
  11. Gandra, 2020, Antimicrobial resistance surveillance in low- and middle-income countries: progress and challenges in eight south Asian and southeast Asian countries, Clin. Microbiol. Rev., 33, e00048, 10.1128/cmr.00048-19 · DOI · Paper page
  12. Garrison, 2015, Halogenated phenazines that potently eradicate biofilms, MRSA persister cells in non-biofilm cultures, and Mycobacterium tuberculosis, Angew. Chem. Int. Ed. Eng., 54, 14819, 10.1002/anie.201508155 · DOI
  13. Gerits, 2017, Repurposing toremifene for treatment of oral bacterial infections, Antimicrob. Agents Chemother., 61, e01846, 10.1128/aac.01846-16 · DOI
  14. Golan, 2019, Current treatment options for acute skin and skin-structure infections, Clin. Infect. Dis., 68, S206, 10.1093/cid/ciz004 · DOI
  15. Harbut, 2015, Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis, Proc. Natl. Acad. Sci. U. S. A., 112, 4453, 10.1073/pnas.1504022112 · DOI · Paper page
  16. Hassan, 2011, Evaluation of different detection methods of biofilm formation in the clinical isolates, Braz. J. Infect. Dis., 15, 305, 10.1016/S1413-8670(11)70197-0 · DOI · Paper page
  17. Joseph, 2016, Cationic pillararenes potently inhibit biofilm formation without affecting bacterial growth and viability, J. Am. Chem. Soc., 138, 754, 10.1021/jacs.5b11834 · DOI · Paper page
  18. Kaplan, 2011, Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide, Antimicrob. Agents Chemother., 55, 3446, 10.1128/AAC.00342-11 · DOI
  19. Kim, 2018, A new class of synthetic retinoid antibiotics effective against bacterial persisters, Nature, 556, 103, 10.1038/nature26157 · DOI · Paper page
  20. Kim, 2019, A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus, Proc. Natl. Acad. Sci. U. S. A., 116, 16529, 10.1073/pnas.1904700116 · DOI · Paper page
  21. Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat. Rev. Microbiol., 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
  22. Li, 2020, High-throughput identification of antibacterials against Pseudomonas aeruginosa, Front. Microbiol., 11, 591426, 10.3389/fmicb.2020.591426 · DOI
  23. Lima, 2021, In-depth characterization of antibacterial activity of melittin against Staphylococcus aureus and use in a model of non-surgical MRSA-infected skin wounds, Eur. J. Pharm. Sci., 156, 105592, 10.1016/j.ejps.2020.105592 · doi:10.1016/j.ejps.2020.105592
  24. Liu, 2020, Metformin restores tetracyclines susceptibility against multidrug resistant bacteria, Adv. Sci., 7, 1902227, 10.1002/advs.201902227 · DOI · Paper page
  25. Liu, 2015, Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains, Emerg. Microbes Infect., 4, e1, 10.1038/emi.2015.17 · doi:10.1038/emi.2015.17
  26. MacNair, 2018, Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics, Nat. Commun., 9, 458, 10.1038/s41467-018-02875-z · DOI · Paper page
  27. Miller, 2020, Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS Microbiol. Rev., 44, 123, 10.1093/femsre/fuz030 · DOI · Paper page
  28. Miró-Canturri, 2020, Repositioning rafoxanide to treat gram-negative bacilli infections, J. Antimicrob. Chemother., 75, 1895, 10.1093/jac/dkaa103 · doi:10.1093/jac/dkaa103
  29. Mori, 2018, Structural basis of thalidomide enantiomer binding to cereblon, Sci. Rep., 8, 1294, 10.1038/s41598-018-19202-7 · DOI
  30. Nosengo, 2016, Can you teach old drugs new tricks?, Nature, 534, 314, 10.1038/534314a · DOI · Paper page
  31. Pletzer, 2018, Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens, PLoS Pathog., 14, e1007084, 10.1371/journal.ppat.1007084 · DOI · Paper page
  32. Qu, 2020, A new coumarin compound DCH combats methicillin-resistant Staphylococcus aureus biofilm by targeting arginine repressor, Sci. Adv., 6, eaay9597, 10.1126/sciadv.aay9597 · DOI
  33. Ranjan, 2016, Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis, Cancer Res., 76, 877, 10.1158/0008-5472.CAN-15-1233 · DOI
  34. Schein, 2020, Repurposing approved drugs on the pathway to novel therapies, Med. Res. Rev., 40, 586, 10.1002/med.21627 · DOI
  35. She, 2020, Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus, Virulence, 11, 636, 10.1080/21505594.2020.1770493 · DOI
  36. She, Efficacy of levofloxacin against biofilms of Pseudomonas aeruginosa isolated from patients with respiratory tract infections in vitro, Microbiology, 8, e00720, 10.1002/mbo3.720 · DOI
  37. She, Synergistic microbicidal effect of auranofin and antibiotics against planktonic and biofilm-encased S. aureus and E. faecalis, Front. Microbiol., 10, 2453, 10.3389/fmicb.2019.02453 · doi:10.3389/fmicb.2019.02453
  38. Smith, 2010, Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 54, 380, 10.1128/AAC.00155-09 · DOI
  39. Soares, 2006, Penfluridol for schizophrenia, Cochrane Database Syst. Rev., 2, Cd002923
  40. Song, 2020, A broad-spectrum antibiotic adjuvant reverses multidrug-resistant gram-negative pathogens, Nat. Microbiol., 5, 1040, 10.1038/s41564-020-0723-z · DOI · Paper page
  41. Su, 2019, Evaluation of platensimycin and platensimycin-inspired thioether analogues against methicillin-resistant Staphylococcus aureus in topical and systemic infection mouse models, Mol. Pharm., 16, 3065, 10.1021/acs.molpharmaceut.9b00293 · DOI
  42. Tan, 2019, Bactericidal and anti-biofilm activity of the retinoid compound CD437 against Enterococcus faecalis, Front. Microbiol., 10, 2301, 10.3389/fmicb.2019.02301 · DOI
  43. Thakare, 2017, Repurposing Ivacaftor for treatment of Staphylococcus aureus infections, Int. J. Antimicrob. Agents, 50, 389, 10.1016/j.ijantimicag.2017.03.020 · doi:10.1016/j.ijantimicag.2017.03.020
  44. Thangamani, 2016, Repurposing auranofin for the treatment of cutaneous staphylococcal infections, Int. J. Antimicrob. Agents, 47, 195, 10.1016/j.ijantimicag.2015.12.016 · DOI
  45. Tuan, 2019, Penfluridol as a candidate of drug repurposing for anticancer agent, Molecules, 24, 3659, 10.3390/molecules24203659 · DOI
  46. Turner, 2019, Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research, Nat. Rev. Microbiol., 17, 203, 10.1038/s41579-018-0147-4 · DOI · Paper page
  47. van Dalen, 2020, Wall teichoic acid in Staphylococcus aureus host interaction, Trends Microbiol., 28, 985, 10.1016/j.tim.2020.05.017 · DOI
  48. Wilson, 2021, Transport of lipopolysaccharides and phospholipids to the outer membrane, Curr. Opin. Microbiol., 60, 51, 10.1016/j.mib.2021.01.006 · DOI
  49. Yasir, 2019, Mechanism of action of surface immobilized antimicrobial peptides against Pseudomonas aeruginosa, Front. Microbiol., 10, 3053, 10.3389/fmicb.2019.03053 · DOI
  50. Zeng, 2021, Drug repurposing: antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis, Microbiology, 10, e1148, 10.1002/mbo3.1148 · DOI
  51. Zhou, 2020, Repurposing antispasmodic agent otilonium bromide for treatment of Staphylococcus aureus infections, Front. Microbiol., 11, 1720, 10.3389/fmicb.2020.01720 · DOI

Cited by

See all 51

Metadata

Authors
Liu, Y., She, P., Xu, L., Chen, L., Li, Y., Liu, S., Li, Z., Hussain, Z., & Wu, Y.
Venue
Frontiers in Microbiology
Published
2021-08-18
Volume
12
ISSN
1664-302X
Cited by
51
References
3
Funders
  • National Natural Science Foundation of China (82072350)
  • Natural Science Foundation of Hunan Province (2019JJ80029)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.